[Covid-19 reinfections: what is the clinical relevance?]
Re-infectie met SARS-CoV-2.
Journal
Nederlands tijdschrift voor geneeskunde
ISSN: 1876-8784
Titre abrégé: Ned Tijdschr Geneeskd
Pays: Netherlands
ID NLM: 0400770
Informations de publication
Date de publication:
03 12 2020
03 12 2020
Historique:
entrez:
17
12
2020
pubmed:
18
12
2020
medline:
14
1
2021
Statut:
epublish
Résumé
Every day additional confirmed case of SARS-CoV-2 reinfection are being reported across the globe. In the Netherlands more than 50 cases of probable reinfections have been identified. With more than 500 thousand people in the Netherlands who have been infected with SARS-CoV-2 up till now this number does seems to be quite low. Still, important questions have to be asked. How do we define reinfection and how do these reinfections compare to other (corona) viruses? What is the immunological significance? What is the duration of protective immunity? And what does Covid-19 reinfections mean for the prevention and development of a vaccine? The described cases of re-infections do teach us that a SARS-CoV-2 vaccine should also be considered for people with a documented Covid-19 infection in the past and that general precautions, such as the use of face masks and social distancing, still apply to those with a previous SARS-CoV-2 infection.
Substances chimiques
COVID-19 Vaccines
0
Types de publication
Journal Article
Langues
dut
Sous-ensembles de citation
IM